Korean J Psychopharmacol.
2005 May;16(3):225-233.
Feasibility of Korean Medication Algorithm for Bipolar Disorder(I): Global Assessment
- Affiliations
-
- 1Department of Psychiatry, Yonsei University College of Medicine, Seoul, Korea.
- 2Department of Neuropsychiatry, College of Medicine, Chung-Ang University, Seoul, Korea.
- 3Kangbuk Samsung Hospital, Department of Psychiatry, School of Medicine, Sungkyunkwan University, Seoul, Korea.
- 4Naju National Hospital, Naju, Korea.
- 5Department of Neuropsychiatry, Ilsan Hospital, National Health Insurance Corporation, Goyang, Korea.
- 6Department of Psychiatry, Seoul National University College of Medicine, Seoul, Korea.
- 7Department of Psychiatry, College of Medicine, Catholic University, Seoul, Korea. wmbahk@catholic.ac.kr
- 8Korean College of Neuropsychopharmacology and Korean Academy of Schizophrenia, Korea.
Abstract
OBJECTIVE
The Korean College of Neuro psychopharmacology and the Korean Academy of Schizophrenia developed the Korean algorithm project for bipolar disorder to aid clinical decisions. The purpose of this study was to assess the feasibility of Korean Medication Algorithm for Bipolar Disorder (KMAP-BP) in clinical settings in Korea. METHODS: A total of 126 bipolar patients were enrolled at 17 centers. Among them, 92 patients were treated according to the algorithm. All subjects were assessed over a 4-month period. Prescribing investigators were able to change the recommended treatment strategies of the algorithm if necessary. RESULTS: Overall ratings were favorable, with investigators stating that the overall quality of this algorithm was "good" or "no need to revise". Of manic patients, the majority (79%) showed treatment response (YMRS improvement > or =50%) at the first stage. CONCLUSION: These results suggest that this algorithm can be useful in clinical practices. However, some problems should be solved in the next version of KMAP-BP.